Literature DB >> 16289583

Insomnia following hypocretin2-saporin lesions of the substantia nigra.

D Gerashchenko1, C A Blanco-Centurion, J D Miller, P J Shiromani.   

Abstract

The neuropeptide hypocretin, also known as orexin, has been implicated in waking since its deletion leads to the sleep disorder narcolepsy. Hypocretin neurons project to major arousal areas, and in an effort to determine which region is responsible for the changes in sleep-wake architecture we have developed the neurotoxin hypocretin2-saporin, which lesions hypocretin receptor bearing neurons. Here, in rats, we investigate the effects of hypocretin2-saporin lesions of the substantia nigra and ventral tegmental area in the regulation of sleep and wakefulness. Bilateral injection of hypocretin2-sap into both the ventral tegmental area and substantia nigra (92 and 184 ng/microl, 0.25 microl in the ventral tegmental area and 0.5 microl in the substantia nigra) or into the substantia nigra alone (184 ng/microl, 0.5 microl) produced insomnia. The insomnia seemed to be associated with a large increase in locomotion on days 4 and 6 postinjection, as hyperactivity and stereotypic movements were consistently observed on the video recordings in all lesioned rats. In these rats, a nearly complete loss of both tyrosine hydroxylase and neuron-specific nuclear protein (neuronal nuclei) immunoreactive cells in the substantia nigra as well as diminution of tyrosine hydroxylase-immunoreactive fibers in the caudate putamen was found. Following bilateral injection of hypocretin2-sap at a lower concentration (46 ng/microl, 0.25 microl in the ventral tegmental area and 0.5 microl in the substantia nigra), very little reduction in the number of tyrosine hydroxylase- and neuronal nuclei-immunoreactive neurons and only a temporary increase in wakefulness (17.4% increase during light-off period on day 6 postinjection) were observed. Ventral tegmental area lesions (184 ng/mul of hypocretin2-sap, 0.25 microl, bilateral injections) did not produce significant changes in sleep, although most of the tyrosine hydroxylase- and neuronal nuclei-immunoreactive neurons in the ventral tegmental area were destroyed. Insomnia following hypocretin2-sap lesions of the substantia nigra could be secondary to increased motor activity resulting from reduction of tonic inhibitory control by the substantia nigra.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289583     DOI: 10.1016/j.neuroscience.2005.08.088

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

1.  Nigrostriatal and mesolimbic control of sleep-wake behavior in rat.

Authors:  Mei-Hong Qiu; Zhi-Gang Zhong; Michael C Chen; Jun Lu
Journal:  Brain Struct Funct       Date:  2019-07-19       Impact factor: 3.270

Review 2.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  Nigrostriatal Dopamine Acting on Globus Pallidus Regulates Sleep.

Authors:  Mei-Hong Qiu; Qiao-Ling Yao; Ramalingam Vetrivelan; Michael C Chen; Jun Lu
Journal:  Cereb Cortex       Date:  2014-10-14       Impact factor: 5.357

4.  Glial Gap Junctions Boost Modafinil Action on Arousal.

Authors:  Jun Lu; Michael Chen
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

5.  The dopaminergic system of the telencephalo-diencephalic areas of the vertebrate brain in the organization of the sleep-waking cycle.

Authors:  G A Oganesyan; I V Romanova; E A Aristakesyan; V V Kuzik; D M Makina; I Yu Morina; A E Khramenkova; I V Artamokhina; V A Belova
Journal:  Neurosci Behav Physiol       Date:  2009-09-23

6.  Sleep and Wakefulness Are Controlled by Ventral Medial Midbrain/Pons GABAergic Neurons in Mice.

Authors:  Yohko Takata; Yo Oishi; Xu-Zhao Zhou; Emi Hasegawa; Koji Takahashi; Yoan Cherasse; Takeshi Sakurai; Michael Lazarus
Journal:  J Neurosci       Date:  2018-10-03       Impact factor: 6.167

7.  Neural circuitry of stress-induced insomnia in rats.

Authors:  Georgina Cano; Takatoshi Mochizuki; Clifford B Saper
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

8.  Optogenetic deconstruction of sleep-wake circuitry in the brain.

Authors:  Antoine Adamantidis; Matthew C Carter; Luis de Lecea
Journal:  Front Mol Neurosci       Date:  2010-01-20       Impact factor: 5.639

9.  Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance.

Authors:  Ramalingam Vetrivelan; Mei-Hong Qiu; Celene Chang; Jun Lu
Journal:  Front Neuroanat       Date:  2010-11-23       Impact factor: 3.856

10.  Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep.

Authors:  Y-Y Lai; K-C Hsieh; D Nguyen; J Peever; J M Siegel
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.